Andrei V. Derbenev, PhD - US grants

The overall goal of this research proposal is to assess the physiological significance of the endocannabinoids (eCBs) in the rostral ventrolateral medulla (RVLM) circuits which regulate cardiovascular function. The central nervous system is directly involved in the regulation of arterial blood pressure (ABP), largely through actions of the sympathetic nervous system on renal function and vasculature. The RVLM is a critical component in the central neural pathway since presympathetic RVLM neurons receive inputs from multiple brain areas and from the spinal cord, and thus mediate many cardiovascular reflexes. Hypertension may result from an imbalance between sympathetic vasomotor neuron activity and those cells that inhibit it. An increase in sympathetic nervous system activity is often associated with disinhibition of RVLM neurons; however, the underlying mechanisms remain unidentified. eCBs are endogenous ligands with a broad range of cardiovascular effects which activate: (1) G protein-coupled cannabinoid type-1 receptor (CB1R), (2) transient receptor potential vanilloid type 1 (TRPV1), or (3) both, indicating a duality of function. Our preliminary data demonstrate that activation of TRPV1 decreases both the excitability of presympathetic RVLM neurons as well as ABP and renal sympathetic nerve activity (RSNA). In addition, TRPV1 expressing neurons were identified in the lateral hypothalamus (LH) and these neurons project to the RVLM. Our multi-disciplinary approaches will use in vivo renal nerve and ABP recordings in rats following eCBs administration into RVLM, optogenetics in combination with telemetry measurements of ABP, fluorescent immunostaining, and in vitro patch-clamp recordings of synaptic currents in identified presympathetic RVLM neurons of transgenic mice. We will test the hypothesis that presympathetic RVLM neurons receive TRPV1 and CB1R expressing inhibitory inputs which determine the excitability of RVLM neurons and thus control ABP. Delineating these mechanisms of brainstem eCBs is essential to predict their impact on the central control of cardiovascular function caused by the activation of TRPV1 and/or CB1R. We believe our results will have clinical significance by providing direct evidence about the regulation of ABP by cannabinoids and will allow the development of novel therapeutic strategies for the treatment of hypertension.

The autonomic nervous system plays a significant role in the regulation of hepatic metabolism. Activation of hepatic sympathetic nerves increases hepatic glucose production (HGP) and glycogenolysis, and increased HGP largely contributes to the pathogenesis of type 2 diabetes mellitus. Therefore, without a full understanding of the neural circuits involved in the regulation of the liver, there is a barrier to develop strategies to control glucose levels via the brain-liver pathway. The overall long-term goal of this proposal is to elucidate the fundamental relationship between central autonomic control and hepatic carbohydrate metabolism. The paraventricular nucleus (PVN) of the hypothalamus is a critical command center controlling autonomic outflow and, thereby, influencing glucose and energy homeostasis. Since impaired glucose homeostasis in diabetic patients involves central circuits controlling autonomic output, the immediate objective of this proposal is to investigate the contribution of pre-sympathetic, liver-related PVN and ventral brainstem neurons to the maintenance of HGP and insulin action using in vivo and in vitro approaches. Our preliminary observations from diet-induced obese (DIO) mice demonstrate an overall shift toward excitation in liver-related PVN neurons and a diminished suppression of excitatory neurotransmission by insulin in pre-sympathetic ventral brainstem projecting PVN neurons. Furthermore, our data also show that liver-related brainstem neurons receive excitatory inputs from PVN neurons. These observations lead to the central hypothesis that monosynaptic connections between pre-sympathetic, liver-related PVN and ventral brainstem neurons are necessary for the regulation of hepatic carbohydrate metabolism. The proposed studies will define hypothalamic and ventral brainstem circuits involved in the sympathetic control of the liver using retrograde viral tracing and circuit mapping in combination with immunostaining. The electrophysiological studies will determine the cellular properties of liver-related neurons in control and DIO mice. Functional connections between PVN and liver-related ventral brainstem neurons will be revealed with optogenetics. The proposed in vivo studies will determine the contribution of liver-related neurons to hepatic glucose production and insulin action. Pharmacogenetic stimulation and inhibition of neurons will be used in combination with hyperinsulinemic-euglycemic clamp studies in conscious intact and adrenalectomized mice. Sympathetic activity will be assessed in a variety of organs and tissues. The outcomes of the proposed studies will establish the contribution of hypothalamic and ventral brainstem circuits to hepatic carbohydrate metabolism, advance our knowledge of sympathetic control of the liver, and may provide new strategies for the improvement of glycemic status in diabetic patients via autonomic control.